Ottawa, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The global iron deficiency anemia therapy market size was valued at USD 5.24 billion in 2024 and is predicted to hit around USD 10.94 billion by 2034, rising ...
Objectives Iron deficiency is common in pregnancy, postpartum, inflammatory bowel disease, chronic kidney disease, chronic heart failure, heavy uterine bleeding, cancer and following surgery. We ...
Inflammatory bowel disease (IBD) is commonly associated with iron deficiency anemia (IDA), with a multifactorial pathophysiology. Diagnosis of both IDA and IBD places patients at risk for poor quality ...